Moxifloxacin Hydrochloride Tablet, Film Coated
Product Images NDC 70518-3738

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride (NDC 70518-3738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Moxifloxacin 400 mg film-coated tablets in a quantity of 7 tablets. The label includes the RX-only status, NDC number 70518-3738-00, and repackaging information by RemedyRepack Inc. It also lists Aurobindo Pharma as the manufacturer located in Dayton, NJ. Warnings about alcohol and nonprescribed drug use and storage instructions are present.*

FDA Label Image

Figure 1 (Moxifloxacin Fig1)

A line graph showing plasma concentration (mcg/mL) versus time (hours) for oral and intravenous doses. The graph compares plasma concentration over 24 hours, with oral dose indicated by circles and intravenous dose by squares, illustrating the concentration decline over time.*

FDA Label Image

Structure (Moxifloxacin Str)

Chemical structure of moxifloxacin hydrochloride showing its molecular framework with specific functional groups and bonds depicted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.